She is a clinical investigator and her research interests include pre-clinical studies investigating disease mechanisms, particularly neuropsychiatric problems of PD; as well as phase II and phase III clinical trials of new treatments for PD and other movement disorders. She is a member of the International Executive Committee of the Movement Disorder Society and is also chair of the Movement Disorder Society Evidence Based Medicine update on treatment of motor symptoms for PD.